Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 28. June 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9458  Previews Next
   
   Articles 1 - 20 / 189143  
   
Deep learning classification of significant prostate cancer on MRI: a systematic review and meta-analysis.
Abdom Radiol (NY)
Chung C, Michalak J, Rubinov Y, Watts K, Kanmaniraja D, Baca A, Hou W, Duong T.
PMID: 42364040 [PubMed - as supplied by publisher]


Accurate focal-plane selection is crucial for artificial intelligence assessment of three-dimensional urine cytology specimens for bladder cancer screening and surveillance.
Cancer Cytopathol
Sayegh Y, McNutt B, Le MK, Liao IC, Yao K, Ng C, Kohsar A, Shou D, Yu M, Jin Y, Vaickus LJ, Liu X, VandenBussche CJ, Harvey SE, Levy JJ.
PMID: 42363782 [PubMed - indexed for MEDLINE]


Long-term trends in the burden of prostate cancer in the United States from 1990 to 2021: A detailed analysis based on the Global Burden of Disease Study 2021.
Medicine (Baltimore)
Guo G, Zhang L, Zhang W, Lin J, Lin H, Li X, Huang P.
PMID: 42363557 [PubMed - in process]


Exploring shared decision-making in prostate cancer screening within primary health care settings in Portugal: a cross-sectional study.
BMC Prim Care
Oliveira B, Lopes L, de Oliveira Branco S, Oliveira S, Granja A, Gonçalves F, Pinto J, Silva M, Coelho S, Fraga A, Teves F.
PMID: 42363103 [PubMed - as supplied by publisher]


Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.
Urol Clin North Am
Hargis P, Baker H, Wiesen B, Kukreja J.
PMID: 42362308 [PubMed - in process]


Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.
Urol Clin North Am
Jiang T, Zhao CC, Liao JC.
PMID: 42362307 [PubMed - indexed for MEDLINE]


Economic Considerations in the Management of Superficial Bladder Cancer.
Urol Clin North Am
Gupta VK, Joyce DD, Wymer KM, Sharma V.
PMID: 42362306 [PubMed - in process]


Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.
Urol Clin North Am
Fu MZ, Sykes J, Pfail J, Packiam VT.
PMID: 42362305 [PubMed - indexed for MEDLINE]


Impact of Social and Structural Determinants of Health on Bladder Cancer Outcomes: Focus on Non-Muscle-Invasive Disease.
Urol Clin North Am
Zhu S, Washington SL 3rd, Sekar R, Chu CE.
PMID: 42362304 [PubMed - in process]


Management of High-Risk Non-Muscle-Invasive Bladder Cancer.
Urol Clin North Am
Tallman JE, Goh AC.
PMID: 42362302 [PubMed - indexed for MEDLINE]


Molecular and Genetic Insights for Personalized Treatment of Non-Muscle-Invasive Bladder Cancer.
Urol Clin North Am
Nolazco JI, Yim K, Salari K.
PMID: 42362301 [PubMed - in process]


Bacillus Calmette-Guérin Therapy: Optimizing Outcomes amid Challenges.
Urol Clin North Am
Tazegul TE, O'Donnell M, Hougen HY.
PMID: 42362300 [PubMed - indexed for MEDLINE]


Emerging Intravesical Therapies for Non-Muscle-Invasive Bladder Cancer.
Urol Clin North Am
Wang B, Isali I, Calaway A, Bukavina L.
PMID: 42362299 [PubMed - in process]


Role of Enhanced Imaging in Superficial Bladder Cancer Management.
Urol Clin North Am
Chou WH, Lechner A, Liu JJ.
PMID: 42362298 [PubMed - in process]


Transurethral Resection of Bladder Tumors: Evolving Standards of Care-Optimizing Resection, Staging Accuracy, and Recurrence Reduction.
Urol Clin North Am
Filon M, Kabra S, Smelser W, Schmidt B.
PMID: 42362297 [PubMed - in process]


Advances in Diagnosis of Non-Muscle-Invasive Bladder Cancer: A Review.
Urol Clin North Am
Higgins MI, Rivera Lopez CA, Lokeshwar SD, Patel SH.
PMID: 42362296 [PubMed - indexed for MEDLINE]


Epidemiology and Risk Factors for Non-Muscle-Invasive Bladder Cancer: Insights into Prevalence, Risk Stratification, and Implications for Early Diagnosis.
Urol Clin North Am
Akinsola O, Bharadwaj M, Psutka SP.
PMID: 42362295 [PubMed - in process]


Extended versus Standard Lymph Node Dissection at the Time of Radical Cystectomy for Bladder Cancer.
Urology
Almohtasib J, Scire E, Kaul S, Fleishman A, Chang P, Wagner A, Bellmunt J, Korets R, Olumi AF, Gershman B.
PMID: 42361989 [PubMed - as supplied by publisher]


The role of acrylamide exposure in prostate cancer progression: An integrated analysis based on network toxicology and experimental validation.
Ecotoxicol Environ Saf
Chen JY, Lin TT, Zheng WC, Yan ZH, Lin B, Liu MX, Wei Y, Xue XY, Zheng QS, Ke ZB, Xu N.
PMID: 42361668 [PubMed - as supplied by publisher]


Association between L-α-glycerylphosphorylcholine use and risk of kidney cancer: A nationwide representative retrospective cohort study.
Cancer Epidemiol
Park YJ, Yu J, Kang JH, Park SJ, Jeong S, Lee G, Shin HY, Park SM.
PMID: 42361543 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 189143    Page 1 of 9458  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1